Clinical Trial
Nov. 17, 2019
JOURNAL：Circulation.
Article Link
Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial
MN Kosiborod, PJhund, KF Docherty et al.
KEYWORDS
dapagliflozin; HFrEF; quality of life; cardiovascular outcomes
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
